InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Munshi Amit, Chief Executive Officer. Insider active across 4 companies, notably Arena Pharmaceuticals INC. In total, 13 reports have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €1.5m. History available since 10 August 2021. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Munshi Amit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
5,778 shares0Common StockSEC:0001628280-26-042041:0
19,089 shares0Common StockSEC:0001193125-26-068063:0
2,021 shares0Common StockSEC:0001628280-25-055927:0
57,265 shares0Common StockSEC:0001193125-25-191463:0
365,000 shares@ US$1.37100.0% of flowCommon StockSEC:0000950170-24-116780:0
Canonical exit: 19 Jan 2025 (T+90)
159,744 shares@ US$3.1333.4% of flowClass A ordinary sharesSEC:0001415889-24-023028:0
159,744 shares@ US$3.1333.4% of flowClass A ordinary sharesSEC:0001415889-24-011480:0
Canonical exit: 21 Jul 2024 (T+90)
117,647 shares@ US$4.2533.2% of flowClass A Ordinary SharesSEC:0001104659-23-068206:0
Canonical exit: 3 Sept 2023 (T+90)
10,500 shares@ US$98.5188.1% of flowCommon StockSEC:0001628280-22-005889:0
85,847 shares0Common StockSEC:0001628280-22-000341:0
1,000 shares@ US$48.193.8% of flowCommon StockSEC:0001628280-21-017167:0
Canonical exit: 14 Nov 2021 (T+90)
1,000 shares@ US$50.414.0% of flowCommon StockSEC:0001628280-21-016916:0
Canonical exit: 10 Nov 2021 (T+90)
1,000 shares@ US$52.9154.2% of flowCommon StockSEC:0001628280-21-016504:0
Canonical exit: 8 Nov 2021 (T+90)
13 of 13 declarations
About Munshi Amit
Munshi Amit is President and CEO. He has 13 filings in total. Across the 13 sampled filings, all acquisitions, the buy volume is EUR 1527322 between 2021-08-11 and 2026-06-09. His listed companies are Arena Pharmaceuticals INC, Inhibikase Therapeutics, Inc., Zura Bio Ltd and Arcutis Biotherapeutics, Inc.
